Total Payments
$20,003
2024 Payments
$304.08
Companies
48
Transactions
928
Medicare Patients
2,229
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$19,257 (96.3%)
Education$746.58 (3.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,257 | 885 | 96.3% |
| Education | $746.58 | 43 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,698 | 152 | $0 (2023) |
| Horizon Therapeutics plc | $2,632 | 97 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $1,648 | 48 | $0 (2019) |
| Amgen Inc. | $1,590 | 74 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $1,570 | 58 | $0 (2023) |
| ABBVIE INC. | $1,186 | 46 | $0 (2024) |
| Horizon Pharma plc | $975.31 | 51 | $0 (2018) |
| Genentech USA, Inc. | $762.46 | 40 | $0 (2020) |
| UCB, Inc. | $598.39 | 40 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $568.88 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $304.08 | 13 | Amgen Inc. ($197.29) |
| 2023 | $1,730 | 69 | Horizon Therapeutics plc ($397.33) |
| 2022 | $3,477 | 145 | Horizon Therapeutics plc ($852.38) |
| 2021 | $1,952 | 105 | Horizon Therapeutics plc ($581.73) |
| 2020 | $2,025 | 80 | Amgen Inc. ($543.74) |
| 2019 | $2,968 | 146 | Mallinckrodt Enterprises LLC ($521.49) |
| 2018 | $4,197 | 200 | Mallinckrodt LLC ($667.55) |
| 2017 | $3,350 | 170 | Janssen Biotech, Inc. ($621.17) |
All Payment Transactions
928 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Inflammation | ||||||
| 06/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Inflammation | ||||||
| 05/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Inflammation | ||||||
| 04/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Inflammation | ||||||
| 01/24/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 11/02/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.39 | General |
| Category: KRYSTEXXA | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Dermatology | ||||||
| 08/03/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Immunology | ||||||
| 08/01/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Inflammation | ||||||
| 07/26/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Immunology | ||||||
| 07/19/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/06/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Dermatology | ||||||
| 06/29/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Immunology | ||||||
| 06/22/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 323 | 4,003 | $585,005 | $150,761 |
| 2022 | 13 | 518 | 10,983 | $1.5M | $397,203 |
| 2021 | 16 | 661 | 14,050 | $1.9M | $570,065 |
| 2020 | 14 | 727 | 16,258 | $2.2M | $686,001 |
Total Patients
2,229
Total Services
45,294
Medicare Billing
$1.8M
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 27 | 115 | $23,000 | $8,209 | 35.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $5,900 | $4,261 | 72.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 26 | 64 | $12,800 | $3,742 | 29.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $5,550 | $3,698 | 66.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 69 | 108 | $8,640 | $2,670 | 30.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2021 | 19 | 525 | $13,125 | $2,342 | 17.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 47 | 181 | $9,000 | $2,320 | 25.8% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 14 | 47 | $8,975 | $1,439 | 16.0% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Office | 2021 | 14 | 17 | $1,700 | $837.46 | 49.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $600.00 | $175.92 | 29.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 12 | 36 | $1,080 | $52.21 | 4.8% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2020 | 27 | 12,675 | $1.9M | $564,439 | 29.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 203 | 611 | $61,100 | $33,194 | 54.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 47 | 246 | $61,950 | $30,950 | 50.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 16 | 1,440 | $36,000 | $22,317 | 62.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 199 | $29,610 | $16,348 | 55.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 132 | 227 | $18,160 | $6,049 | 33.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 29 | 67 | $13,400 | $3,457 | 25.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $3,800 | $2,310 | 60.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 56 | 194 | $9,700 | $2,302 | 23.7% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2020 | 25 | 425 | $10,625 | $2,079 | 19.6% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2020 | 19 | 44 | $7,200 | $1,230 | 17.1% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 54 | 65 | $4,875 | $1,135 | 23.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 13 | $650.00 | $176.26 | 27.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 11 | 33 | $475.00 | $15.87 | 3.3% |
About Dr. Miguel Cima, MD
Dr. Miguel Cima, MD is a Internal Medicine healthcare provider based in Garden City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053374868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miguel Cima, MD has received a total of $20,003 in payments from pharmaceutical and medical device companies, with $304.08 received in 2024. These payments were reported across 928 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($19,257).
As a Medicare-enrolled provider, Cima has provided services to 2,229 Medicare beneficiaries, totaling 45,294 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Garden City, NY
- Active Since 04/11/2006
- Last Updated 04/21/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053374868
Products in Payments
- ACTHAR (Biological) $3,218
- KRYSTEXXA (Biological) $2,256
- SIMPONI ARIA (Biological) $844.38
- TREMFYA (Drug) $840.77
- RAYOS (Drug) $839.07
- RINVOQ (Biological) $729.74
- STELARA (Biological) $627.71
- Cimzia (Drug) $598.39
- Otezla (Drug) $505.84
- KRYSTEXXA (Drug) $490.01
- COSENTYX (Biological) $469.13
- ORENCIA (Biological) $444.98
- EVENITY (Biological) $388.73
- REMICADE (Biological) $381.64
- Rituxan (Biological) $374.98
- Actemra (Biological) $372.52
- BENLYSTA (Biological) $369.72
- SAPHNELO (Biological) $346.41
- XELJANZ (Drug) $316.81
- TAVNEOS (Drug) $302.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Garden City
Samuel Sigal, Md, MD
Internal Medicine — Payments: $71,923
Internal Medicine $71,923
Dr. Vivek Sengupta, D.o, D.O
Internal Medicine — Payments: $44,381
Internal Medicine $44,381
Dr. Anis Toumeh, M.d, M.D
Internal Medicine — Payments: $29,357
Internal Medicine $29,357
Marc Levine, Md, MD
Internal Medicine — Payments: $20,976
Internal Medicine $20,976
Lotika Singh, M.d, M.D
Internal Medicine — Payments: $12,217
Internal Medicine $12,217
William Harder, D.o, D.O
Internal Medicine — Payments: $6,573
Internal Medicine $6,573